clinical trial · NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Novo Nordisk A/S·phase3·recruiting·n = 1,150
ObesityNNC0487-0111Placebo (matched to NNC0487-0111)
brief summary
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
started
Feb 24, 2026
primary completion
Jun 26, 2029
completion
Aug 21, 2029
last updated
Apr 7, 2026
official title
Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol